Together Startup Network Ltd
Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company was incorporated in 1991 and is based in Ashkelon, Israel.
Together Startup Network Ltd (TGTR) - Net Assets
Latest net assets as of June 2019: ILA-20.31 Million ILA
Based on the latest financial reports, Together Startup Network Ltd (TGTR) has net assets worth ILA-20.31 Million ILA as of June 2019.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA35.72 Million) and total liabilities (ILA56.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA-20.31 Million |
| % of Total Assets | -56.85% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -351.62% |
| Growth Volatility | 25917.8 |
Together Startup Network Ltd - Net Assets Trend (2008–2018)
This chart illustrates how Together Startup Network Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Together Startup Network Ltd (2008–2018)
The table below shows the annual net assets of Together Startup Network Ltd from 2008 to 2018.
| Year | Net Assets | Change |
|---|---|---|
| 2018-12-31 | ILA-29.60 Million | -74090.00% |
| 2017-12-31 | ILA40.00K | -89.50% |
| 2016-12-31 | ILA381.00K | -68.01% |
| 2015-12-31 | ILA1.19 Million | +736.90% |
| 2014-12-31 | ILA-187.00K | -1458.33% |
| 2013-12-31 | ILA-12.00K | -103.72% |
| 2012-12-31 | ILA323.00K | -41.17% |
| 2011-12-31 | ILA549.00K | +254.19% |
| 2010-12-31 | ILA155.00K | -98.68% |
| 2009-12-31 | ILA11.76 Million | +314.71% |
| 2008-12-31 | ILA-5.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Together Startup Network Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12309700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2018)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA120.14 Million | % |
| Total Equity | ILA-29.75 Million | 100.00% |
Together Startup Network Ltd Competitors by Market Cap
The table below lists competitors of Together Startup Network Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Konan Technology Inc.
KQ:402030
|
$124.46K |
|
Nuveen Multi-Asset Income Fund
NYSE:NMAI
|
$124.57K |
|
TI Fluid Systems PLC
LSE:TIFS
|
$124.63K |
|
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN
|
$124.82K |
|
XRPR
BATS:XRPR
|
$124.20K |
|
AngioSoma Inc
PINK:GSTC
|
$124.11K |
|
Cbd Life Sciences Inc
PINK:CBDL
|
$124.07K |
|
J M AB
BE:JMM
|
$124.05K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Together Startup Network Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2017 to 2018, total equity changed from 366,000 to -29,753,000, a change of -30,119,000 (-8229.2%).
- Net loss of 149,863,000 reduced equity.
- Other factors increased equity by 119,744,000.
Equity Change Factors (2017 to 2018)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-149.86 Million | -503.69% |
| Other Changes | ILA119.74 Million | +402.46% |
| Total Change | ILA- | -8229.23% |
Book Value vs Market Value Analysis
This analysis compares Together Startup Network Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Together Startup Network Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (91.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | -20.22% | 1.27x | 0.00x | ILA-11.63 Million |
| 2009 | 129.90% | 21.81% | 1.31x | 4.56x | ILA14.10 Million |
| 2010 | 703.87% | 2.02% | 176.02x | 1.98x | ILA1.08 Million |
| 2011 | 387.98% | 17.56% | 14.36x | 1.54x | ILA2.08 Million |
| 2013 | 0.00% | -376.97% | 0.54x | 0.00x | ILA-1.29 Million |
| 2014 | 0.00% | -72.11% | 0.70x | 0.00x | ILA-1.39 Million |
| 2015 | -32.91% | -12.57% | 0.80x | 3.27x | ILA-511.10K |
| 2016 | -264.83% | -190.02% | 0.24x | 5.88x | ILA-1.05 Million |
| 2017 | -9.29% | 0.00% | 0.00x | 1.50x | ILA-70.60K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-146.89 Million |
Industry Comparison
This section compares Together Startup Network Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $18,570,030
- Average return on equity (ROE) among peers: -47.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Together Startup Network Ltd (TGTR) | ILA-20.31 Million | 0.00% | N/A | $124.45K |
| Canzon Israel Ltd (CNZN) | $7.46 Million | -32.77% | 0.24x | $18.43K |
| Intercure (INCR) | $24.07 Million | 1.10% | 0.15x | $367.38K |
| Nextage Therapeutics Ltd (NXTG) | $-1.65 Million | 0.00% | 0.00x | $70.01K |
| Rekah Pharmaceutical Industry Ltd (REKA) | $48.86 Million | 18.05% | 3.13x | $385.28K |
| Seach Medical Group Ltd (SEMG) | $-362.00K | 0.00% | 0.00x | $278.78K |
| Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) | $33.04 Million | -269.00% | 1.32x | $75.63K |